JPWO2019189945A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019189945A5
JPWO2019189945A5 JP2020551599A JP2020551599A JPWO2019189945A5 JP WO2019189945 A5 JPWO2019189945 A5 JP WO2019189945A5 JP 2020551599 A JP2020551599 A JP 2020551599A JP 2020551599 A JP2020551599 A JP 2020551599A JP WO2019189945 A5 JPWO2019189945 A5 JP WO2019189945A5
Authority
JP
Japan
Prior art keywords
methyl
difluoromethoxy
group
fluoro
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020551599A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519294A5 (https=
JP2021519294A (ja
JP7279067B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/014901 external-priority patent/WO2019189945A1/en
Publication of JP2021519294A publication Critical patent/JP2021519294A/ja
Publication of JP2021519294A5 publication Critical patent/JP2021519294A5/ja
Publication of JPWO2019189945A5 publication Critical patent/JPWO2019189945A5/ja
Application granted granted Critical
Publication of JP7279067B2 publication Critical patent/JP7279067B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020551599A 2018-03-28 2019-03-27 複素環化合物及びその用途 Active JP7279067B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018062939 2018-03-28
JP2018062939 2018-03-28
PCT/JP2019/014901 WO2019189945A1 (en) 2018-03-28 2019-03-27 Heterocyclic compound and use thereof

Publications (4)

Publication Number Publication Date
JP2021519294A JP2021519294A (ja) 2021-08-10
JP2021519294A5 JP2021519294A5 (https=) 2022-04-01
JPWO2019189945A5 true JPWO2019189945A5 (https=) 2022-04-01
JP7279067B2 JP7279067B2 (ja) 2023-05-22

Family

ID=66397395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020551599A Active JP7279067B2 (ja) 2018-03-28 2019-03-27 複素環化合物及びその用途

Country Status (17)

Country Link
US (2) US10807987B2 (https=)
EP (1) EP3774800B1 (https=)
JP (1) JP7279067B2 (https=)
KR (1) KR20200136957A (https=)
CN (1) CN111936495A (https=)
AR (1) AR115020A1 (https=)
AU (1) AU2019241765B2 (https=)
BR (1) BR112020018238A2 (https=)
CA (1) CA3100133A1 (https=)
EA (1) EA202092294A1 (https=)
ES (1) ES3006012T3 (https=)
IL (1) IL276912A (https=)
MA (1) MA52214A (https=)
MX (1) MX2020010148A (https=)
SG (1) SG11202008519RA (https=)
TW (1) TW202003519A (https=)
WO (1) WO2019189945A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3660003B1 (en) 2017-07-28 2024-01-24 Takeda Pharmaceutical Company Limited Heterocyclic compound
US10807987B2 (en) * 2018-03-28 2020-10-20 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
JP2021050161A (ja) 2019-09-25 2021-04-01 武田薬品工業株式会社 複素環化合物及びその用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
US5252563A (en) * 1991-12-19 1993-10-12 G. D. Searle & Company 5,6,7,8-tetrahydro-imidazo[1,2-a]pyrimidine compounds for treatment of neurotoxic injury
JP3439551B2 (ja) * 1994-11-08 2003-08-25 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
EP0815134B1 (en) 1995-03-14 2002-06-05 Praecis Pharmaceuticals Incorporated Modulators of amyloid aggregation
PT929574E (pt) 1996-08-27 2005-11-30 Praecis Pharm Inc Moduladores da agregacao de peptidos beta-amiloides compreendendo d-aminoacidos
US6331640B1 (en) 1998-10-13 2001-12-18 Hoffmann-La Roche Inc. Diaminopropionic acid derivatives
EP1196609A2 (en) 1999-06-28 2002-04-17 Oklahoma Medical Research Foundation Catalytically active recombinant memapsin and methods of use thereof
WO2002080928A1 (en) * 2001-04-03 2002-10-17 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
JP2004161716A (ja) * 2002-11-15 2004-06-10 Takeda Chem Ind Ltd Jnk阻害剤
MXPA05010824A (es) * 2003-04-10 2005-12-05 Pfizer Compuestos biciclicos como antagonistas del receptor nr2b.
EP1919872A4 (en) 2005-08-31 2009-08-05 Smithkline Beecham Corp CHEMICAL COMPOUNDS
MX2011008276A (es) * 2009-02-06 2011-12-14 Elan Pharm Inc Inhibidores de quinasa jun n-terminal.
US8404859B2 (en) 2011-03-16 2013-03-26 Hoffmann-La Roche Inc. Thiazole and thiophene compounds
ES2581848T3 (es) * 2011-04-05 2016-09-07 Pfizer Limited Derivados de pirrolo[2,3-d]pirimidina como inhibidores de quinasas relacionadas con tropomiosina
FR2998892B1 (fr) 2012-12-04 2015-01-02 Pf Medicament Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments
CA2903572A1 (en) 2013-03-15 2014-10-23 Epizyme, Inc. Substituted benzene compounds
US9243001B2 (en) 2013-03-15 2016-01-26 Epizyme, Inc. Substituted benzene compounds
US10202376B2 (en) 2014-12-24 2019-02-12 Takeda Pharmaceutical Company Limited Heterocyclic compound
JP6827757B2 (ja) 2016-10-11 2021-02-10 鬼怒川ゴム工業株式会社 ウエザーストリップ取付用クリップ
EP3660003B1 (en) * 2017-07-28 2024-01-24 Takeda Pharmaceutical Company Limited Heterocyclic compound
US10807987B2 (en) * 2018-03-28 2020-10-20 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
WO2020153414A1 (ja) * 2019-01-24 2020-07-30 武田薬品工業株式会社 複素環化合物及びその用途
WO2020196828A1 (ja) * 2019-03-28 2020-10-01 武田薬品工業株式会社 含窒素複素環化合物

Similar Documents

Publication Publication Date Title
JP6181862B2 (ja) ピラゾロピロリジン誘導体および疾患の処置におけるその使用
JP4823914B2 (ja) Fgfr3の阻害および多発性骨髄腫の治療
JP7012152B2 (ja) Fshdの治療のためにdux4および下流遺伝子発現を低減するp38キナーゼ阻害剤
JP5832647B2 (ja) がんの治療における使用のためのcdk4/6阻害剤およびpi3k阻害剤を含む併用療法
KR102307566B1 (ko) 신규한 바이사이클릭 브로모도메인 억제제
JP2021500345A5 (https=)
JP2019535728A (ja) キナーゼ阻害剤としての複素環式アミド
JP2013523884A5 (https=)
JP6695353B2 (ja) Fgfr4阻害剤としてのホルミル化n−複素環式誘導体
JP2017530185A5 (https=)
TW201429957A (zh) 用於激酶調節及其適應症之化合物及方法
JP2013501749A5 (https=)
AU2015308522A1 (en) Products for the treatment and prevention of neurological disorders coursing with a cognition deficit or impairment, and of neurodegenerative diseases
JP2020503302A5 (https=)
US20190105311A1 (en) P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
JP2020512401A5 (https=)
JP2021519294A5 (https=)
JP2019505558A5 (https=)
JPWO2019189945A5 (https=)
JP2009500366A5 (https=)
JPWO2021126731A5 (https=)
TW202116301A (zh) 藥物組合及其用途
JP2014525929A5 (https=)
JPWO2019198692A5 (https=)
PL200537B1 (pl) Środek leczniczy do zapobiegania i leczenia schizofrenii oraz zastosowanie